Verition Fund Management’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
LA
KC
MF
AA
WAM
MC
HCM
LP
TCM
AIMCA
Verition Fund Management's TDAC Position: Q2 2026 in Review
Verition Fund Management reduced its Translational Development Acquisition Corp (TDAC) stake by 72% in Q2 2026, selling an estimated $1.31M and leaving 46,687 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.
Verition Fund Management first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.18M in Q1 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.
- Verition Fund Management held 46,687 shares of Translational Development Acquisition Corp worth $499K as of Q2 2026.
- Verition Fund Management sold 122,416 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1.31M.
- Translational Development Acquisition Corp made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1636 holding.
- Verition Fund Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
- Verition Fund Management's Translational Development Acquisition Corp position peaked at $2.18M in Q1 2025.
- 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.